# Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin

> **NCT03801746** · PHASE1 · COMPLETED · sponsor: **Akebia Therapeutics** · enrollment: 40 (actual)

## Conditions studied

- Drug Interaction Potentiation

## Interventions

- **DRUG:** vadadustat
- **DRUG:** Rifampin
- **DRUG:** Probenecid
- **DRUG:** Cyclosporins

## Key facts

- **NCT ID:** NCT03801746
- **Lead sponsor:** Akebia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-20
- **Primary completion:** 2018-08-15
- **Final completion:** 2018-08-15
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03801746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03801746, "Drug-Drug Interaction Study of Vadadustat With Cyclosporine, Probenecid and Rifampin". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03801746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*